Bicaveral Glucose 1.5% Calcium 1.75mmol/L Peritoneal Dialysis Solution
Sodium Chloride 5.786g · Sodium Bicarbonate 2.94g +3 more
Solution · Prescription medication · Combination
Fresenius Medical Care Korea Co., Ltd.
MFDS item code 201902588 · Approved 2019.04.25 · Insurance code 664300631
Peritoneal dialysis treatment in patients with chronic renal failure
The peritoneal dialysis solution is used when patients with chronic kidney failure have difficulty removing waste products and excess fluid from the body due to decreased kidney function. This medication helps to efficiently expel waste products, electrolytes, and water from the blood using the peritoneum. It plays a significant role in assisting kidney function and stabilizing the internal environment. The peritoneal dialysis solution is essential in the dialysis treatment process, used to sustain the lives and improve the health of patients.
This medicine must be administered intraperitoneally. The attending physician adjusts the treatment regimen, number of treatments, and dwell time according to the patient's condition. It must be administered daily as prescribed and must not be discontinued without authorization before starting any other renal replacement therapy. Generally, 2000 mL is infused into the peritoneal cavity 4 times daily and drained after 2~10 hours. The dose should be adjusted individually for each patient. If the patient experiences pain due to abdominal distension during peritoneal dialysis, first reduce the volume infused per exchange to 500~1500 mL. Increase the dose for patients with no residual renal function and a large body size; for these patients, or for patients who tolerate a larger infusion volume, the dose may be increased to 2500 mL per exchange. When peritoneal dialysis is performed intermittently or continuously using a peritoneal dialysis device, use a package size larger than the exchange volume per treatment (3,000 mL or 5,000mL). If body weight exceeds the target dry weight, use a peritoneal dialysis solution with a higher glucose concentration (2.3 % or 4.25 %).
For children, adjust the dose according to age, body size, and body weight (30~40 mL/kg).
This medication is a dialysis solution used for peritoneal dialysis, having an electrolyte composition similar to that of blood, helping to remove waste and excess fluid from the body. There is a risk of life-threatening situations if peritoneal dialysis is discontinued prematurely without receiving alternative renal replacement therapy, so caution is advised. This drug should not be used in patients with severe hypokalemia or severe hypercalcemia, those with recent abdominal surgery or injury, severe abdominal inflammation, inflammatory bowel disease, peritonitis, abdominal hernias, lung diseases, sepsis, hyperlipidemia, significant weight loss, and other conditions. Patients with electrolyte loss due to vomiting or diarrhea, those taking calcium-containing drugs, digitalis agents, diuretics, or diabetic patients should exercise special caution while using this drug and regularly check electrolyte levels in the blood. This medication is generally safe, but side effects may include electrolyte imbalance, fluid imbalance, increased blood sugar, hyperlipidemia, and weight gain. Serious complications may occur, including peritonitis, catheter infections, infusion and drainage issues with the peritoneal dialysis solution, gastrointestinal problems, respiratory difficulties, hernias, abdominal distension, shoulder pain, and rarely, encapsulating peritoneal sclerosis. Patients should immediately consult a physician if symptoms appear. Regular monitoring of weight, electrolyte levels in the blood, kidney function, and blood sugar is required while using this drug, and dialysis methods may need to be adjusted if peritoneal function declines. Effects of other medications dialyzed through the peritoneum may be reduced, so dose adjustments may be necessary when using co-administered drugs. Caution should be exercised when using this drug during pregnancy or lactation, and pediatric doses should be adjusted according to weight and physique. Elderly patients have a higher risk of hernia, so evaluation prior to peritoneal dialysis is necessary. In cases of overdose, excessive accumulation of dialysis solution in the peritoneum may occur, so avoid excessive dosing and inform healthcare professionals of any abnormal symptoms. This drug must be used in a sterile condition; do not use if the container is damaged or if the liquid is turbid. Unused dialysis solution should not be reused and should be discarded, keeping it out of reach of children. This drug is known not to affect driving or machine operating abilities.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a sealed container to protect it from air and moisture. It is best to maintain the storage temperature between 4 and 25 degrees Celsius to preserve the drug's efficacy and safety for an extended period.
Before mixing (Solution A, Solution B): A colorless and transparent peritoneal dialysis solution in a colorless and transparent plastic container. After mixing (Mixed solution): A single colorless and transparent liquid divided into two spaces by a single partition.
2000 mL/bag, 5000 mL/bag
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sodium Chloride 5.786g · Sodium Bicarbonate 2.94g +3 more
Solution · Prescription medication · Combination
Fresenius Medical Care Korea Co., Ltd.
Calcium Chloride Hydrate 4.41g · Magnesium Chloride Hexahydrate 2.033g +3 more
Prescription medication · Combination
Fresenius Medical Care Korea Co., Ltd.
Sodium Chloride 5.786g · Sodium Bicarbonate 2.94g +3 more
Solution · Prescription medication · Combination
Fresenius Medical Care Korea Co., Ltd.
Sodium Chloride 5.786g · Sodium Bicarbonate 2.94g +3 more
Solution · Prescription medication · Combination
Fresenius Medical Care Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.